1. Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037). (December 2020) Authors: Banerjee, Susana; Tovey, Holly; Bowen, Rebecca; Folkerd, Elizabeth; Kilburn, Lucy; McLachlan, Jennifer; Hall, Marcia; Tunariu, Nina; Attygalle, Ayoma; Lima, Joao Paulo Da Silveira Nogueira; Perry, Sophie; Chatfield, Peter; Hills, Margaret; Kaye, Stan; Attard, Gert; Dowsett, Mitch; Bliss, Judith M. Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗